Membrane Blue Versus Infracyanine Green
Launched by THE LUDWIG BOLTZMANN INSTITUTE OF RETINOLOGY AND BIOMICROSCOPIC LASER SURGERY · Nov 7, 2007
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Macular pucker or macular hole
- Exclusion Criteria:
- • Any other retinal disease
About The Ludwig Boltzmann Institute Of Retinology And Biomicroscopic Laser Surgery
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery is a leading research institution dedicated to advancing the field of ophthalmology through innovative clinical trials and cutting-edge technologies. Focused on retinology and laser surgery, the institute aims to enhance patient outcomes by developing and validating novel therapeutic approaches and diagnostic tools. With a commitment to excellence in research and a collaborative environment, the institute brings together a multidisciplinary team of experts to drive forward the frontiers of eye care and address pressing challenges in visual health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Katharina E Schmid-Kubista, MD
Principal Investigator
Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials